Stressor-Focused Therapy for Emotional Processing in Adjustment Disorder (STEP)
STEP - Stressor-focused Therapy for Emotional Processing in ICD-11 Adjustment Disorder: A Randomised Waitlist-Controlled Trial
This randomized controlled trial evaluates the efficacy of STEP, a brief 12-session psychotherapy for adults with ICD-11 Adjustment Disorder (AjD). STEP is a manualized, CBT-based, event-focused intervention designed to reduce Adjustment Disorder symptoms and support adaptive emotional processing and coping. Participants in the waitlist control group will receive STEP after the 12-week waiting period. Outcomes will be assessed at baseline, post-treatment, and at a 3-month follow-up. The primary outcome is Adjustment Disorder symptom severity. Secondary outcomes include perceived stress, depression, anxiety, well-being, and experiential avoidance.
研究概览
详细说明
Adjustment disorder (AjD) is characterised in ICD-11 by two core symptom clusters: preoccupation with the stressor and failure to adapt. Although adjustment disorder is frequently diagnosed in clinical practice, evidence for disorder-specific psychological treatments based on the ICD-11 conceptualisation remains limited.
STEP (Stressor-focused Therapy for Emotional Processing) was developed to address these core symptoms through a structured, event-focused cognitive-behavioural approach. The treatment is based on the conceptualisation of adjustment disorder as a stress-response syndrome, in which persistent preoccupation with a stressful life event and avoidance of associated memories, thoughts, and emotions may contribute to symptom maintenance.
Drawing on established cognitive-behavioural and trauma-focused treatment principles, STEP integrates psychoeducation, individual case formulation, emotional awareness and regulation, event-focused imaginal exposure, cognitive restructuring, resource activation, and adaptive coping strategies. A central component is the guided emotional processing of distressing life events and emotionally salient moments associated with the stressor. The intervention aims to reduce maladaptive avoidance and preoccupation, facilitate emotional processing, and support adaptation to changed life circumstances.
This randomised waitlist-controlled trial evaluates the efficacy of STEP in adults diagnosed with ICD-11 adjustment disorder. The primary hypothesis is that participants receiving STEP will demonstrate greater reductions in adjustment disorder symptoms than participants assigned to the waitlist condition. Secondary objectives include examining changes in psychological distress, experiential avoidance, and subjective well-being, as well as evaluating treatment feasibility and acceptability.
The study is expected to contribute to the development of targeted, evidence-based psychotherapeutic interventions for adjustment disorder.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Rahel Bachem, Prof. Dr.
- 电话号码:+41 58 257 35 26
- 邮箱:rahel.bachem@ost.ch
学习地点
-
-
Canton of St. Gallen
-
Sankt Gallen、Canton of St. Gallen、瑞士、9001
- Competence Center for Mental Health; Eastern Switzerland University of Applied Sciences
-
接触:
- Rahel Bachem, Prof. Dr.
- 电话号码:+41 58 257 35 26
- 邮箱:rahel.bachem@ost.ch
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age ≥ 18 years
- Diagnosis of ICD-11 Adjustment Disorder confirmed via structured clinical interview using the IADQ diagnostic algorithm
- Presence of a clearly identifiable psychosocial stressor 2 weeks to 2 years before participation
- Sufficient German language proficiency to participate in psychotherapy and complete study assessments
- Capacity to provide written informed consent
Exclusion Criteria:
- Current PTSD or CPTSD meeting ICD-11 diagnostic criteria following a Criterion A traumatic event
- Current prolonged grief disorder meeting ICD-11 diagnostic criteria
- Lifetime history of bipolar disorder or psychotic disorder, including schizophrenia spectrum disorders
- Severe depressive or anxiety symptoms clearly predating the identified stressor and judged to better account for the current clinical presentation
- Another severe mental disorder that would interfere with participation in psychotherapy or better explain the presenting symptoms
- Acute suicidality requiring immediate crisis intervention
- Ongoing psychotherapy
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:STEP Intervention Group
Participants assigned to the intervention group receive 12 weekly sessions of the STEP psychotherapy intervention after completion of the baseline assessment. |
STEP is a brief, manualized, 12-session CBT-based psychotherapy specifically developed for ICD-11 Adjustment Disorder (AjD). It follows a staged, event-focused approach targeting the core symptom clusters of preoccupation and failure to adapt. Treatment components include psychoeducation and individualized case conceptualization, emotional awareness and regulation skills, stressor-focused imaginal exposure and emotional processing, cognitive and emotional reprocessing of stressor-related meanings, strengthening of personal resources and adaptive coping strategies, and relapse prevention. |
|
其他:Waitlist Control Group
Participants assigned to the waitlist control group do not receive the STEP intervention during the 12-week waiting period. After completion of the waiting period, participants receive the STEP intervention. |
STEP is a brief, manualized, 12-session CBT-based psychotherapy specifically developed for ICD-11 Adjustment Disorder (AjD). It follows a staged, event-focused approach targeting the core symptom clusters of preoccupation and failure to adapt. Treatment components include psychoeducation and individualized case conceptualization, emotional awareness and regulation skills, stressor-focused imaginal exposure and emotional processing, cognitive and emotional reprocessing of stressor-related meanings, strengthening of personal resources and adaptive coping strategies, and relapse prevention. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Adjustment Disorder Symptom Severity at Post-Treatment
大体时间:Week 12-14 after baseline (T1; post-treatment in the immediate intervention group and post-waiting period in the control group)
|
Adjustment disorder symptom severity is assessed using the International Adjustment Disorder Questionnaire (IADQ). The primary outcome is the sum of six symptom items (Items 1-6), covering preoccupation with the stressor and failure to adapt. Each item is rated from 0 to 4, resulting in a total score ranging from 0 to 24, with higher scores indicating greater symptom severity. Scores at T1 will be compared between groups, adjusting for baseline scores. |
Week 12-14 after baseline (T1; post-treatment in the immediate intervention group and post-waiting period in the control group)
|
|
Depressive Symptom Severity
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the International Depression Questionnaire (IDQ), measuring depressive symptoms according to ICD-11. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Anxiety Symptom Severity
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the International Anxiety Questionnaire (IAQ), measuring symptoms of generalized anxiety according to ICD-11. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
|
Perceived Stress
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the 10-item Perceived Stress Scale (PSS-10), measuring the perceived level of stress. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
|
Subjective Well-Being
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the World Health Organization-Five Well-Being Index (WHO-5), measuring subjective psychological well-being. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
|
Experiential Avoidance
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the Brief Experiential Avoidance Questionnaire (BEAQ), measuring the tendency to avoid unwanted internal experiences. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
|
Adjustment Disorder Diagnostic Status
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed through a structured clinical interview evaluating the presence or absence of ICD-11 adjustment disorder and diagnostic remission. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
|
Treatment Credibility and Expectancy
大体时间:Immediately after STEP Session 1
|
Assessed using the Credibility/Expectancy Questionnaire (CEQ), measuring treatment credibility and expected improvement. |
Immediately after STEP Session 1
|
|
Treatment Acceptability and Feasibility
大体时间:Immediately after completion of the 12-session STEP treatment
|
Assessed using the Treatment Feedback and Adherence questionnaire (TFA), evaluating participants' experiences with STEP. |
Immediately after completion of the 12-session STEP treatment
|
|
Event-Focused Repetitive Thoughts
大体时间:Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
Assessed using the Event-focused Repetitive Thoughts Questionnaire (ERTQ), measuring repetitive thoughts related to stressful life events. |
Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
|
合作者和调查者
赞助
出版物和有用的链接
一般刊物
- Bachem R, Maercker A. Self-help interventions for adjustment disorder problems: a randomized waiting-list controlled study in a sample of burglary victims. Cogn Behav Ther. 2016 Sep;45(5):397-413. doi: 10.1080/16506073.2016.1191083. Epub 2016 Jun 14.
- Levin Y, Bachem R, Hyland P, Karatzias T, Shevlin M, Ben-Ezra M, Maercker A. Validation of the International Adjustment Disorder Questionnaire in Israel and Switzerland. Clin Psychol Psychother. 2022 Jul;29(4):1321-1330. doi: 10.1002/cpp.2710. Epub 2022 Jan 20.
- Bachem R, Casey P. Adjustment disorder: A diagnosis whose time has come. J Affect Disord. 2018 Feb;227:243-253. doi: 10.1016/j.jad.2017.10.034. Epub 2017 Oct 23.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- STEP_PILOTSTUDY
- PT0041_222855 (其他赠款/资助编号:Swiss National Science Foundation - SNSF)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
A fully anonymized individual participant dataset will be made available in a publicly accessible scientific repository (e.g., OSF) following publication of the primary study results. All direct identifiers will be removed, and indirect identifiers will be minimized to prevent re-identification. No identifiable or coded participant data will be shared.
IPD 共享时间框架
The anonymized individual participant dataset will become publicly available following publication of the primary study results. The dataset will remain accessible for as long as it is maintained in the selected public scientific data repository.
IPD 共享访问标准
The fully anonymized dataset will be publicly accessible to researchers and other interested users through an open scientific data repository, such as the Open Science Framework (OSF), without an individual access request. The shared dataset will contain numerical questionnaire data and broadly categorized demographic information. Free-text descriptions, exact age, geographical information, direct identifiers, and coded participant data will not be made publicly available. A data dictionary will accompany the dataset.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.